HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Illicit drugs | Image credit: Stanislau_V - stock.adobe.com
SDOH Domains at Risk Correlated With Substance Use in People With HIV

May 2nd 2025

Correlation to social drivers of health (SDOH) had an important correlation with polysubstance use.

HIV | Image credit: reddish - stock.adobe.com
Family Dynamics, Mental Health Influence Adherence to ART

April 29th 2025

Richard Hughes IV, JD, MPH
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

April 21st 2025

Women with HIV | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com
Poor Well-Being in HIV Associated With SDOH Adversities

April 16th 2025

Money | Image credit: Stillfx - stock.adobe.com
Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

April 3rd 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
May 2nd 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

PrEP Initiation Associated With Increased STI Incidence Among Gay, Bisexual Men
April 11th 2019

PrEP Initiation Associated With Increased STI Incidence Among Gay, Bisexual Men

Jaime Rosenberg
A study of gay and bisexual men found that incidence of sexually transmitted infections (STIs) increased following pre-exposure prophylaxis (PrEP) initiation.
Can Couple-Based Interventions Prevent the Spread of HIV?
April 5th 2019

Can Couple-Based Interventions Prevent the Spread of HIV?

Wallace Stephens
Researchers evaluated differences in effectiveness of 2 couple-based preventive interventions aimed to reduce the spread of HIV and sexually transmitted infections among individuals in community supervision programs.
Weighing Management Strategies for HIV Medication Safety, Cost
April 4th 2019

Weighing Management Strategies for HIV Medication Safety, Cost

Jaime Rosenberg
While medical advances have improved lifespan and quality of life for patients with HIV, there are still opportunities for strategies that address both medication safety and costs.
Dr Ian Frank on the Convenience, Benefits of Single-Tablet Regimens for HIV
March 30th 2019

Dr Ian Frank on the Convenience, Benefits of Single-Tablet Regimens for HIV

People living with HIV who are taking single-tablet regimens have better medication adherence and lower hospitalizations than those taking multi-tablet regimens, explained Ian Frank, MD, professor of medicine, Perelman School of Medicine, University of Pennsylvania,
5 Findings From the AMCP Managed Care & Specialty Pharmacy Annual Meeting
March 29th 2019

5 Findings From the AMCP Managed Care & Specialty Pharmacy Annual Meeting

Jaime Rosenberg
During the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmcy Annual Meeting, held March 25-28, in San Diego, California, managed care professionals from across the globe gathered to discuss opportunities and challenges facing stakeholders in pharmaceutical management, ranging from drug pricing reform to strategies to address the opioid epidemic.
What We're Reading: New Healthcare Giant; Monsanto Lawsuit; Organ Transplants From Donor with HIV
March 28th 2019

What We're Reading: New Healthcare Giant; Monsanto Lawsuit; Organ Transplants From Donor with HIV

AJMC Staff
Insurer Centene strikes a deal to acquire WellCare, creating a new giant in the healthcare market; a federal jury orders Monsanto to pay over $80 million to a plaintiff whose cancer was found to be caused by a common weed killer; surgeons perform a transplant using a kidney from a living donor with HIV.
Can Staggered Care Save Money While Achieving Viral Suppression in Youth With HIV?
March 27th 2019

Can Staggered Care Save Money While Achieving Viral Suppression in Youth With HIV?

Wallace Stephens
In an ongoing study, researchers seek to determine whether a staggered, "step up" intervention model could be more successful and cost-effective than standard care for achieving viral suppression in youths living with HIV.
Recommendations Discuss When Patients on ART Can Consider ATI
March 23rd 2019

Recommendations Discuss When Patients on ART Can Consider ATI

Allison Inserro
Recently published consensus recommendations discuss analytical antiretroviral treatment interruption (ATI), including who can be included and excluded and when to restart antiretroviral therapy (ART).
This Week in Managed Care: March 22, 2019
March 22nd 2019

This Week in Managed Care: March 22, 2019

This week, the top managed care news included new primary prevention guidelines that could increase the use of some diabetes drugs; the FDA expanded criteria for which patients can take part in clinical trials; a summit on value-based insurance design showed the need for tough conversations with stakeholders.
CDC Says New HIV Transmissions Stem From Lack of Treatment, Unawareness of Infection
March 20th 2019

CDC Says New HIV Transmissions Stem From Lack of Treatment, Unawareness of Infection

Wallace Stephens
The majority of new HIV infections have been found to be transmitted by individuals who are unaware that they have HIV or by those who know they have HIV but are not receiving treatment to suppress their infection.
Participation in Community Groups Found to Increase Awareness of PrEP
March 16th 2019

Participation in Community Groups Found to Increase Awareness of PrEP

Wallace Stephens
Gay or bisexual men who participated in community groups were found have a higher awareness of pre-exposure prophylaxis (PrEP) than those who did not. PrEP has proven to be a successful preventive measure to decrease the spread of HIV.
Proposed 2020 White House Budget Includes Block Grants, Medicaid Work Rules, Increased HIV Funding
March 12th 2019

Proposed 2020 White House Budget Includes Block Grants, Medicaid Work Rules, Increased HIV Funding

Jaime Rosenberg Allison Inserro
The president has released his budget for fiscal year (FY) 2020, which calls for converting Medicaid to a system of block grants and requiring all able-bodied Medicaid recipients to hold a job or perform community service. The $87.1 billion allocated to HHS, a 12% cut, would include increases to federal HIV funding, but drops in global funding, as well as cuts to the National Institutes of Health (NIH).
Dr Paul Sax Outlines Effective Treatments for Multidrug-Resistant HIV
March 9th 2019

Dr Paul Sax Outlines Effective Treatments for Multidrug-Resistant HIV

Most patients with multidrug-resistant HIV can still be treated with existing therapies, explained Paul Sax, MD, clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital and professor of medicine at Harvard University.
This Week in Managed Care: March 8, 2019
March 8th 2019

This Week in Managed Care: March 8, 2019

This week, the top managed care news included Scott Gottlieb, MD, resigning as FDA commissioner; Eli Lilly offering a discounted version of Humalog; and a second patient reported cured of HIV.
Is There a Future for Effective Vaccines for Infectious Diseases?
March 8th 2019

Is There a Future for Effective Vaccines for Infectious Diseases?

Jaime Rosenberg
This is part 1 of a 3-part vaccine series covering the potential of vaccines for infectious diseases, the impact of the antivaccination movement, and the promise of vaccines for cancer treatment.
What We're Reading: HIV Cured in Second Patient; Patients Question FDA; China Creating Ethics Committee
March 5th 2019

What We're Reading: HIV Cured in Second Patient; Patients Question FDA; China Creating Ethics Committee

AJMC Staff
A second patient has been reported to have been cured of infection with HIV since the start of the epidemic; thousands have reported complications to the FDA with medical devices and implants; a 30-person national ethics committee has been appointed in China to oversee high-risk clinical trials.
Estimating the Cost-Effectiveness of PrEP Over 40 Years
March 2nd 2019

Estimating the Cost-Effectiveness of PrEP Over 40 Years

Wallace Stephens
Short-term investments pertaining to the distribution of PrEP are expected to result in long-term cost-savings and promote significant health benefits following its introduction in Germany, according to a new modelling study.
HIV, Hepatitis C Drugs Continue to Be Most Costly Group of Outpatient Drugs for Medicaid
February 28th 2019

HIV, Hepatitis C Drugs Continue to Be Most Costly Group of Outpatient Drugs for Medicaid

Jaime Rosenberg
Between 2014 and 2017, antivirals were consistently the number 1 most costly outpatient drug group for Medicaid, and HIV antiretrovirals and hepatitis C drugs accounted for more than 90% of spending on these antivirals.
Dr W. David Hardy: Efforts Needed for President Trump's Plan to End HIV Epidemic in 10 Years
February 20th 2019

Dr W. David Hardy: Efforts Needed for President Trump's Plan to End HIV Epidemic in 10 Years

W. David Hardy, MD, adjunct professor of medicine, Johns Hopkins University, discusses the importance of identifying patients with undiagnosed HIV and preventing new infections for accomplishing President Trump's plan to end the HIV epidemic in 10 years.
What We're Reading: Young Blood Injections; Gilead Accused of Kickbacks; Minor Consent for PrEP
February 20th 2019

What We're Reading: Young Blood Injections; Gilead Accused of Kickbacks; Minor Consent for PrEP

AJMC Staff
The FDA is warning against services offering to inject older adults with younger people's blood plasma; Gilead is being accused of providing kickbacks to providers to boost sales of its drugs; and a bill in Maryland would allow minors to consent to preventive treatment for HIV.
What We're Reading: Kaiser Permanente's Tuition Offer; Menopause and the Brain; Air Force and HIV
February 19th 2019

What We're Reading: Kaiser Permanente's Tuition Offer; Menopause and the Brain; Air Force and HIV

AJMC Staff
Kaiser Permanente will waive annual tuition for the first 5 classes of its new medical school, following a similar move by the New York University School of Medicine; menopause is typically thought of in terms of the end of fertility, but more attention is being paid to the effects of the lack of estrogen on the brain; a federal judge has ordered the US Air Force to temporarily stop discharging service members who are HIV-positive.
Diagnosis and Treatment of Cognitive Impairment in HIV Patients
February 19th 2019

Diagnosis and Treatment of Cognitive Impairment in HIV Patients

Wallace Stephens
As survival rates for people living with HIV continue to increase and the population grows older, cognitive impairment is becoming more common.
Study Will Follow Outcomes of HIV-to-HIV Liver Transplants
February 14th 2019

Study Will Follow Outcomes of HIV-to-HIV Liver Transplants

Jaime Rosenberg
The HOPE in Action Multicenter Liver Study will determine the safety of 80 HIV-to-HIV liver transplants.
Immunotherapy Is Safe, Effective in Patients With Cancer Living With HIV
February 12th 2019

Immunotherapy Is Safe, Effective in Patients With Cancer Living With HIV

Jaime Rosenberg
A systematic review has found that immune checkpoint inhibitors are safe in patients with cancer living with HIV, and that these patients have similar objective response rates for certain cancers that have been seen in uninfected patients with cancer.
Podcast: This Week in Managed Care—State of the Union Health Initiatives and Other Health News
February 10th 2019

Podcast: This Week in Managed Care—State of the Union Health Initiatives and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: February 8, 2019
February 8th 2019

This Week in Managed Care: February 8, 2019

This week, the top managed care news included President Trump's State of the Union address highlighting healthcare; HHS Secretary Alex Azar taking on drug rebates; and physicians asking Congress to fully implement the HITECH Act.
HIV Experts Across HHS Outline Plan for Ending HIV Epidemic Within 10 Years
February 7th 2019

HIV Experts Across HHS Outline Plan for Ending HIV Epidemic Within 10 Years

Jaime Rosenberg
Following President Trump’s second State of the Union address, where he announced plans to end the HIV epidemic, HIV experts from across HHS outlined a comprehensive plan of action focusing on diagnosis, treatment, prevention, and response.
Trump Highlights New Initiatives for Childhood Cancer, HIV in State of the Union
February 6th 2019

Trump Highlights New Initiatives for Childhood Cancer, HIV in State of the Union

Laura Joszt, MA
During his second State of the Union address, President Trump highlighted past bipartisan accomplishments, such as legislation to confront the opioid crisis, but also outlined future priorities, such as addressing the cost of healthcare and prescription drugs.
What We're Reading: Trump May Include HIV Plan in Speech; Judge Tosses ACA Suit; CF Treatment Gaps
February 4th 2019

What We're Reading: Trump May Include HIV Plan in Speech; Judge Tosses ACA Suit; CF Treatment Gaps

AJMC Staff
While President Trump's State of the Union address is not finalized, he may plan to unveil a promise to end HIV transmission in America by 2030; a federal judge dismissed a lawsuit brought by Maryland that claimed the Trump administration is failing to enforce the Affordable Care Act; new cystic fibrosis (CF) treatments targeting the genetic mutations that cause the disease help about 90% of patients, meaning that 10% are still waiting for a cutting-edge therapy.
ACC/AHA Cholesterol Guidelines Increased Statin Eligibility for Patients With HIV, But Challenges Persist
February 2nd 2019

ACC/AHA Cholesterol Guidelines Increased Statin Eligibility for Patients With HIV, But Challenges Persist

Jaime Rosenberg
When the American College of Cardiology/American Heart Association (ACC/AHA) released new cholesterol guidelines in 2013, replacing older guidelines and changing statin eligibility, more patients with HIV became recommended for statin therapy. However, many patients are still not recommended for or prescribed the treatment.
<1
...
181920212223242526
...
32>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo